Physician profile
Jayant Dey
NPI 1740251941
$1,482.19
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,310 · 2020: $172.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $193.17 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $183.41 | 2019-2020 | |
| Novo Nordisk INC | $178.94 | 2019-2020 | |
| Amgen INC. | $115.78 | 2019-2020 | |
| Shire North American Group INC | $112.85 | 2019 | |
| Merck Sharp & Dohme LLC | $85.26 | 2019 | |
| Corcept Therapeutics | $83.87 | 2019-2020 | |
| Insulet Corporation | $56.85 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $53.78 | 2019-2020 | |
| Medtronic Minimed, INC. | $51.49 | 2019 | |
| Dexcom, INC. | $44.73 | 2019-2020 | |
| Amarin Pharma, INC. | $44.18 | 2019 | |
| Eisai INC. | $42.94 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $40.64 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $38.37 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $33.68 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.58 | 2019 | |
| Vivus LLC | $20.33 | 2019 | |
| Mannkind Corporation | $18.35 | 2019 | |
| Pfizer INC. | $17.80 | 2019 | |
| Abbvie INC. | $14.18 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayant Dey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.